| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/21/2013 | CN103255169A Replication-defective arenavirus vectors |
| 08/21/2013 | CN103254315A Recombinant TAT-MANF (trans-activator of transcription-mesencephalic astrocyte derived neurotrophic factor) fusion protein and application thereof |
| 08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
| 08/21/2013 | CN103254127A Glycine-reuptake inhibitor and application thereof |
| 08/21/2013 | CN103254088A Tapentadol hydrochloride crystal form D as well as preparation method and application thereof |
| 08/21/2013 | CN103251959A Novel use of fruit fly gene lk6 |
| 08/21/2013 | CN103251957A Treatment of spinal cord injury by transplanting stem cells modified by neurotrophic factor gene |
| 08/21/2013 | CN103251953A Flt3 inhibitors for immune suppression |
| 08/21/2013 | CN103251951A Application of P2X2 receptor agonist or opening agent in preparation of anti-depression or anti-anxiety drugs |
| 08/21/2013 | CN103251937A Medicaments and methods for treating headache |
| 08/21/2013 | CN103251932A Application of hepcidin in preparation of medicine for treating iron-associated neurodegenerative diseases |
| 08/21/2013 | CN103251916A Chinese herb preparation for treating peripheral neuritis |
| 08/21/2013 | CN103251914A Medicament for treating rheumatoid bone diseases |
| 08/21/2013 | CN103251890A Plant essential oil composition and anxiolytic effect thereof |
| 08/21/2013 | CN103251888A Chinese medicine composition for treating depression |
| 08/21/2013 | CN103251884A Traditional Chinese medicine for treating Alzheimer disease as well as preparation method and application thereof |
| 08/21/2013 | CN103251882A Pharmaceutical composition for treating tumor |
| 08/21/2013 | CN103251875A Pain-relieving traditional Chinese medicine preparation and preparation method thereof |
| 08/21/2013 | CN103251861A Traditional Chinese medicine composition for treating headache |
| 08/21/2013 | CN103251821A Medicine for treating wind-heat headache and migraine headache and preparation method of medicine |
| 08/21/2013 | CN103251819A Nervous headache treatment traditional Chinese medicine composition |
| 08/21/2013 | CN103251817A Traditional Chinese medicine for headaches |
| 08/21/2013 | CN103251815A Zhuyan medicinal liquor |
| 08/21/2013 | CN103251803A Formula and process of health-assistant wine |
| 08/21/2013 | CN103251802A Appearance paste and preparation method thereof |
| 08/21/2013 | CN103251796A Traditional Chinese medicine for treating insomnia |
| 08/21/2013 | CN103251757A Borneol-containing compound preparation as well as preparation method and application thereof |
| 08/21/2013 | CN103251755A Chinese medicinal preparation for treating facial neuritis |
| 08/21/2013 | CN103251720A Plaster for treating facial paralysis |
| 08/21/2013 | CN103251698A Puerarin beverage with effects of dispelling alcoholism, protecting liver and protecting stomach and preparation method thereof |
| 08/21/2013 | CN103251697A Medicinal composition for treating diabetic peripheral neuropathy, and preparation method thereof |
| 08/21/2013 | CN103251681A Cistanche sinensis extract as well as preparation method and application thereof |
| 08/21/2013 | CN103251679A Refreshing massage gel and preparation method thereof |
| 08/21/2013 | CN103251635A Application of 2-[(2-O-glucosyl-5-hydroxybenzoyl) amino]-5-hydroxybenzoic acid methyl ester |
| 08/21/2013 | CN103251631A Salicylate conjugates useful for treating metabolic disorders |
| 08/21/2013 | CN103251619A Application of Aspeverin in preparation of antidepressant medicines |
| 08/21/2013 | CN103251608A Application of Myriberine A in preparation of medicines for treating Alzheimer disease |
| 08/21/2013 | CN103251597A Naltrexone long acting formulations and methods of use |
| 08/21/2013 | CN103251578A Application of danshinolic acid A for preparing medicament for preventing and treating alzheimer disease |
| 08/21/2013 | CN103251567A Agomelatine troche and preparation method thereof |
| 08/21/2013 | CN103251554A Stable edaravone injection and preparation method thereof |
| 08/21/2013 | CN102911879B Chaetomium globosum and application thereof |
| 08/21/2013 | CN102805812B Preparation method of traditional Chinese medicine for treating insomnia due to garlic adephagia |
| 08/21/2013 | CN102698242B Black plaster for treating waist and knee joint pains |
| 08/21/2013 | CN102697766B Application of N-methyl piperonylethylamine and salts of N-methyl piperonylethylamine in preparation of drugs for preventing and/or treating encephalopathy |
| 08/21/2013 | CN102670714B Semen raphani Chinese medicine oral liquid for relieving high blood pressure and preparation method of same |
| 08/21/2013 | CN102631436B Medicament for treating encephalatrophy |
| 08/21/2013 | CN102579403B Duloxetine hydrochloride drug composition |
| 08/21/2013 | CN102552156B Nimodipine freeze-dried solid lipid nanoparticle and preparation method thereof |
| 08/21/2013 | CN102526129B Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder |
| 08/21/2013 | CN102284053B Foot bathing preparation for treating insomnia |
| 08/21/2013 | CN102247477B Method for preparing bezoar soft capsules |
| 08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
| 08/21/2013 | CN102099337B Piperazine derivatives used as cav2.2 calcium channel modulators |
| 08/21/2013 | CN102066359B Novel heteroaryl carboxamide derivatives |
| 08/21/2013 | CN101910143B Condensed aminodihydrothiazine derivative |
| 08/21/2013 | CN101861316B Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
| 08/21/2013 | CN101856363B Application of Bortezomib in preparing drugs for curing POEMS syndrome |
| 08/21/2013 | CN101790517B Inhibitor of binding of s1p1 |
| 08/21/2013 | CN101784533B 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 08/21/2013 | CN101664553B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/21/2013 | CN101600700B Novel 2-aminooxazolines as taar1 ligands for CNS disorders |
| 08/21/2013 | CN101547915B Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists |
| 08/21/2013 | CN101544592B Process for preparation of N-arylsulfonyl-3-substituted indoles |
| 08/21/2013 | CN101484410B Terphenyl derivatives for treatment of alzheimer's disease |
| 08/21/2013 | CN101472891B Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 08/21/2013 | CN101194964B Coated tablet for treating headache and method for preparing the same |
| 08/20/2013 | US8513387 Methods and compositions for detecting amyotrophic lateral sclerosis |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/20/2013 | US8513246 Use of N-heterocyclylmethylbenzamides in therapeutics |
| 08/20/2013 | US8513238 Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands |
| 08/20/2013 | US8513220 Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity |
| 08/20/2013 | US8513198 Pharmaceutical formulation for reducing pain |
| 08/20/2013 | US8513027 Method of identifying an inhibitor of the prostanoid EP4 receptor |
| 08/20/2013 | US8512994 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512993 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512767 Pharmaceutical compositions |
| 08/20/2013 | US8512709 Modified amyloid β peptide |
| 08/20/2013 | CA2736281C Tri-substituted pyrimidine compounds and their use as pde10 inhibitors |
| 08/20/2013 | CA2669800C Nerve elongation promoter and elongation inhibitor |
| 08/20/2013 | CA2651451C Extended release oral multimicroparticle dosage form |
| 08/20/2013 | CA2606262C Novel histamine h3-receptor ligands and their therapeutic applications |
| 08/20/2013 | CA2602445C Metabolites for nk-i antagonists for emesis |
| 08/20/2013 | CA2545503C Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
| 08/20/2013 | CA2516563C Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 08/20/2013 | CA2429180C Discordant helix stabilization for prevention of amyloid formation |
| 08/15/2013 | WO2013119985A1 C-terminal hsp90 inhibitors |
| 08/15/2013 | WO2013119800A1 Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| 08/15/2013 | WO2013119794A1 Modified release formulations of viloxazine |
| 08/15/2013 | WO2013119791A1 Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use |
| 08/15/2013 | WO2013119605A1 Promoting sleep using at1 receptor blockers |
| 08/15/2013 | WO2013119042A1 Composition for preventing or curing neuropathic pain comprising substance-p |
| 08/15/2013 | WO2013117693A1 Pde4 inhibitor for treating huntington's disease |
| 08/15/2013 | WO2013117288A1 Tetrahydro-quinazolinone derivatives as tank and parp inhibitors |
| 08/15/2013 | WO2013117285A1 Furo [3, 2 - b] - and thieno [3, 2 - b] pyridine derivatives as tbk1 and ikk inhibitors |
| 08/15/2013 | WO2013093122A3 Antibodies for the treatment and diagnosis of affective and anxiety disorders |